Related Experiment Video
Updated: Feb 9, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Association of Circulating Chemerin With Subclinical Parameters of Atherosclerosis: Results of a Population-Based
Stephanie Zylla1,2, Marcus Dörr3,2, Henry Völzke4,2
1From the Institute of Clinical Chemistry and Laboratory Medicine (S.Z., M.N., N.F.) stephanie.zylla@uni-greifswald.de.
Insights
Plasma chemerin levels show an inverse association with ankle-brachial index, a marker of peripheral artery disease. This finding suggests chemerin
Area of Science:
- Cardiovascular Research
- Biomarker Discovery
- Metabolic Syndrome
Background:
- Chemerin is linked to inflammation and metabolic syndrome, key atherosclerosis risk factors.
- Existing research on chemerin's role in atherosclerosis presents conflicting results.
- Investigating chemerin's association with subclinical atherosclerosis is crucial.
Purpose of the Study:
- To examine the relationship between plasma chemerin levels and subclinical atherosclerosis measures.
- To clarify the role of chemerin in different stages and arterial regions of atherosclerosis.
Main Methods:
- Analysis of data from 4003 participants in the Study of Health in Pomerania (SHIP).
- Utilized linear and logistic regression models to assess associations with atherosclerotic parameters.
- Adjusted for metabolic and inflammatory factors to refine findings.
Main Results:
- A significant inverse association was found between chemerin and ankle-brachial index (ABI).
- Increased chemerin levels correlated with a higher likelihood of low ABI.
- No significant association was observed between chemerin and carotid intima-media thickness, plaque, or stenosis after adjustments.
Conclusions:
- A modest inverse association exists between chemerin and ABI, independent of metabolic and inflammatory markers.
- Chemerin's association with atherosclerosis may vary by arterial region and disease stage.
- Further research is needed to elucidate chemerin's specific role in cardiovascular risk stratification.
Objective:
Chemerin has been shown to be associated with inflammation and metabolic syndrome, which are in turn leading risk factors for atherosclerosis. A few clinical studies have concentrated on the role of chemerin in atherosclerosis but revealed divergent findings. Therefore, we aimed to investigate the association of plasma chemerin levels with different subclinical measurements of atherosclerosis in a population-based sample.
Approach And Results:
Linear and logistic regression models with different atherosclerotic parameters as subclinical outcomes were applied to analyze data from 4003 subjects of the SHIP (Study of Health in Pomerania). After adjustment for metabolic and inflammatory parameters, these models revealed no association of chemerin with carotid intima-media thickness, carotid plaque, or carotid stenosis but a significant inverse association between chemerin and ankle-brachial index. In detail, logistic regression analysis showed that a 25-ng/mL increase in chemerin was associated with a 30% higher odd (95% confidence interval, 1.20-1.41) of having an ankle-brachial index value below the 25th age- and sex-specific quartile.
Conclusions:
Our analyses revealed a modest inverse association between chemerin and ankle-brachial index that remained consistent after adjustment for metabolic and inflammatory parameters. The association of chemerin with carotid intima-media thickness, carotid plaque, or carotid stenosis was not significant after adjustment for the same confounder set. The investigated subclinical atherosclerotic parameters are representative for the atherosclerotic burden of different arterial regions and different disease stages. Thus, our results might suggest that the value of chemerin as a marker of higher atherosclerotic risk differs depending on the affected arterial region and disease stage.
Related Concept Videos
Distributions to Estimate Population Parameter
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Atherosclerosis III: Management
What is Population Genetics?
Atherosclerosis I: Introduction
What are Populations and Communities?

